Suchergebnisse - "Christopher Kuaban"

PubPharm (22)

1

Individual and healthcare supply-related HIV transmission factors in HIV-positive patients enrolled in the antiretroviral treatment access program in the Centre and Littoral regions in Cameroon (ANRS-12288 EVOLCam survey).

in: PLoS ONE | 2022

von Pierre-Julien Coulaud | Abdourahmane Sow | Luis Sagaon-Teyssier | +8

2

Free access to antiretroviral treatment and protection against the risk of catastrophic health expenditure in people living with HIV: evidence from Cameroon

in: BMC Health Services Research | 2021

von Marwân-al-Qays Bousmah | Marie Libérée Nishimwe | Christopher Kuaban | +1

3

Incidence and factors associated with unfavourable treatment outcome among patients with rifampicin-resistant pulmonary tuberculosis in Yaoundé, Cameroon

in: The Pan African Medical Journal | 2021

von Alain Kuaban | Adamou Dodo Balkissou | Marie Christine Essadi Ekongolo | +3

4

Intimate partner violence by men living with HIV in Cameroon: Prevalence, associated factors and implications for HIV transmission risk (ANRS-12288 EVOLCAM).

in: PLoS ONE | 2021

von Marion Fiorentino | Abdourahmane Sow | Luis Sagaon-Teyssier | +9

5

Transmission patterns of rifampicin resistant Mycobacterium tuberculosis complex strains in Cameroon: a genomic epidemiological study

in: BMC Infectious Diseases | 2021

von Matthias Merker | Nkongho F. Egbe | Yannick R. Ngangue | +7

6

Parental and child-level predictors of HIV testing uptake, seropositivity and treatment initiation among children and adolescents in Cameroon.

in: PLoS ONE | 2020

von Habakkuk A Yumo | Rogers A Ajeh | Isidore Sieleunou | +5

7

Treatment outcomes and factors associated with unfavourable outcome among previously treated tuberculosis patients with isoniazid resistance in four regions of Cameroon

in: The Pan African Medical Journal | 2020

von Christopher Kuaban | Louise Daniele Ingrid Toukam | Melissa Sander

8

Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)

in: BMC Infectious Diseases | 2020

von Florian Liégeois | Sylvie Boyer | Sabrina Eymard-Duvernay | +12

9

Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries

in: EClinicalMedicine | 2020

von Valérie Schwœbel | Arnaud Trébucq | Zacharie Kashongwe | +16

10

Effectiveness of symptom-based diagnostic HIV testing versus targeted and blanket provider-initiated testing and counseling among children and adolescents in Cameroon.

in: PLoS ONE | 2019

von Habakkuk A Yumo | Rogers A Ajeh | Marcus Beissner | +5